{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:56:52Z","timestamp":1791997012068,"version":"4.4.0"},"reference-count":84,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Gall bladder carcinoma (GBC) remains a formidable diagnostic and therapeutic challenge, characterized by its often-incidental discovery and diverse spectrum of lesions, spanning from benign mimickers to malignant neoplasms. This review synthesizes the complex pathological landscape of GBC, highlighting regional epidemiological variations, intricate etiopathogenetic mechanisms, and the evolving array of diagnostic modalities. Emphasis is placed on the diagnostic ambiguity and histological diversity inherent to gall bladder lesions, which frequently obscure early detection and optimal management. The article explores the interplay between genetic and environmental risk factors, scrutinizes advances in molecular pathology, and considers the potential of liquid biopsy for noninvasive diagnosis and monitoring. By dissecting both traditional and cutting-edge approaches\u2014including immunohistochemistry, emerging biomarkers, and molecular profiling\u2014the review aims to illuminate current standards and future directions in the diagnosis and management of GBC. Additionally, the authors address surgical strategies, the role of immunotherapy, and the significance of identifying histologic mimics and subtypes that impact prognosis and treatment planning. Through a robust literature review conducted using curated MeSH terms, this article aspires to bridge gaps in existing knowledge, particularly for underrepresented regions, and to serve as a valuable resource for clinicians and pathologists confronting the diagnostic labyrinth of GBC.<\/jats:p>","DOI":"10.4103\/ijpm.ijpm_649_25","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:24:15Z","timestamp":1764937455000},"page":"676-691","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Tumors and tumor-like lesions of the gall bladder\u2014A review"],"prefix":"10.4103","volume":"68","author":[{"given":"Nuzhat","family":"Husain","sequence":"first","affiliation":[{"name":"Department of Pathology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumya","family":"Shukla","sequence":"additional","affiliation":[{"name":"Department of Pathology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Department of Pathology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"R1-20251208","first-page":"319","article-title":"Congenital malformations of the gallbladder and cystic duct diagnosed by laparoscopy:High surgical risk","volume":"3","author":"Carbajo","year":"1999","journal-title":"JSLS"},{"key":"R2-20251208","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jviscsurg.2014.05.003","article-title":"Gallbladder tumor and pseudotumor:Diagnosis and management","volume":"151","author":"Zemour","year":"2014","journal-title":"J Visc Surg"},{"key":"R3-20251208","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1590\/S1516-31802008000400004","article-title":"Intestinal metaplasia in gallbladders:Prevalence study","volume":"126","author":"Fernandes","year":"2008","journal-title":"Sao Paulo Med J"},{"key":"R4-20251208","doi-asserted-by":"crossref","first-page":"386","DOI":"10.5858\/2005-129-386-PPOGDA","article-title":"Putative precursors of gallbladder dysplasia:A review of 400 routinely resected specimens","volume":"129","author":"Mukhopadhyay","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"R5-20251208","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jviscsurg.2017.06.004","article-title":"Gallbladder adenomyomatosis:Diagnosis and management","volume":"154","author":"Golse","year":"2017","journal-title":"J Visc Surg"},{"key":"R6-20251208","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.mpdhp.2010.06.001","article-title":"Benign tumors and tumor-like lesions of the gallbladder and extrahepatic biliary tract","volume":"16","author":"Van","year":"2010","journal-title":"Diagn Histopathol"},{"key":"R7-20251208","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1007\/s00464-020-07828-6","article-title":"Xanthogranulomatous cholecystitis:A review of 31 patients","volume":"35","author":"Makimoto","year":"2021","journal-title":"Surg Endosc"},{"key":"R8-20251208","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1615\/JLongTermEffMedImplants.v15.i3.90","article-title":"Cholelithiasis and cholecystitis","volume":"15","author":"Schirmer","year":"2005","journal-title":"J Long Term Eff Med Implants"},{"key":"R9-20251208","first-page":"182","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"J Cutan Pathol"},{"key":"R10-20251208","first-page":"229","article-title":"Global cancer statistics 2022:Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R11-20251208","doi-asserted-by":"crossref","first-page":"33","DOI":"10.21037\/cco.2019.08.03","article-title":"Epidemiology of gallbladder cancer in India","volume":"8","author":"Dutta","year":"2019","journal-title":"Chin Clin Oncol"},{"key":"R12-20251208","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s12029-025-01212-0","article-title":"Incidental gallbladder cancer:A comprehensive review","volume":"56","author":"Kumar","year":"2025","journal-title":"J Gastrointest Cancer"},{"key":"R13-20251208","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12253-014-9886-3","article-title":"Pathology of gallbladder carcinoma:Current understanding and new perspectives","volume":"21","author":"Bal","year":"2015","journal-title":"Pathol Oncol Res"},{"key":"R14-20251208","first-page":"285","article-title":"Is there a role for estrogen and progesterone receptors in gall bladder cancer?HPB","volume":"9","author":"Shukla","year":"2007"},{"key":"R15-20251208","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12029-012-9458-2","article-title":"Association of mustard oil as cooking media with carcinoma of the gallbladder","volume":"44","author":"Dixit","year":"2013","journal-title":"J Gastrointest Cancer"},{"key":"R16-20251208","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/0019-509X.13766","article-title":"A review of association of dietary factors in gallbladder cancer","volume":"41","author":"Rai","year":"2004","journal-title":"Indian J Cancer"},{"key":"R17-20251208","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/jso.20528","article-title":"Gallstones and gallbladder cancer-volume and weight of gallstones are associated with gallbladder cancer:A case-control study","volume":"93","author":"Roa","year":"2006","journal-title":"J Surg Oncol"},{"key":"R18-20251208","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00008469-200302000-00004","article-title":"Risk factors for gallbladder cancer:A reappraisal","volume":"12","author":"Pandey","year":"2003","journal-title":"Eur J Cancer Prev"},{"key":"R19-20251208","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1007\/s00268-013-2164-9","article-title":"Heavy and trace metals in carcinoma of the gallbladder","volume":"37","author":"Basu","year":"2013","journal-title":"World J Surg"},{"key":"R20-20251208","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/01.pas.0000213435.99492.8a","article-title":"Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis:Evidence for a metaplasia-dysplasia-carcinoma sequence","volume":"31","author":"Lewis","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R21-20251208","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1155\/2007\/383949","article-title":"Gallbladder carcinoma associated with anomalous pancreaticobiliary duct junction","volume":"21","author":"Kang","year":"2007","journal-title":"Can J Gastroenterol"},{"key":"R22-20251208","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.gastha.2023.12.005","article-title":"The broad spectrum of gallbladder paraneoplastic syndromes","volume":"3","author":"Ali","year":"2023","journal-title":"Gastro Hep Adv"},{"key":"R23-20251208","doi-asserted-by":"crossref","first-page":"100280","DOI":"10.1016\/j.jlb.2024.100280","article-title":"Liquid biopsy in gallbladder carcinoma:Current evidence and future prospective","volume":"6","author":"Mishra","year":"2024","journal-title":"J Liq Biopsy"},{"key":"R24-20251208","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/diagnostics14050475","article-title":"The many hidden faces of gallbladder carcinoma on CT and MRI imaging-from A to Z","volume":"14","author":"Neculoiu","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"R25-20251208","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/dc.24517","article-title":"Diagnostic role of fine needle aspiration cytology (FNAC) in the evaluation of gall bladder lesions:An institutional experience","volume":"48","author":"Selhi","year":"2020","journal-title":"Diagn Cytopathol"},{"key":"R26-20251208","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.3748\/wjg.v19.i31.5150","article-title":"Radical lymph node dissection and assessment:Impact on gallbladder cancer prognosis","volume":"19","author":"Liu","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R28-20251208","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/PAS.0000000000001237","article-title":"Intracholecystic papillary neoplasms are distinct from papillary gallbladder cancers:A clinicopathologic and exome-sequencing study","volume":"43","author":"Akita","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R29-20251208","doi-asserted-by":"crossref","first-page":"147","DOI":"10.32074\/1591-951X-251","article-title":"Benign biliary neoplasms and biliary tumor precursors","volume":"113","author":"Sarcognato","year":"2021","journal-title":"Pathologica"},{"key":"R30-20251208","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1097\/PAS.0000000000001536","article-title":"Neuroendocrine carcinomas of the gallbladder:A clinicopathologic and immunohistochemical analysis of 34 resected cases","volume":"44","author":"Lee","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R31-20251208","doi-asserted-by":"crossref","first-page":"152244","DOI":"10.1016\/j.anndiagpath.2023.152244","article-title":"Primary gallbladder melanoma:A systematic review of literature","volume":"68","author":"Rehman","year":"2024","journal-title":"Ann Diagn Pathol"},{"key":"R32-20251208","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/0974-2727.154803","article-title":"Primary B-cell non-hodgkin lymphoma of gallbladder presenting as cholecystitis","volume":"7","author":"Katiyar","year":"2015","journal-title":"J Lab Physicians"},{"key":"R33-20251208","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s00277-013-1963-2","article-title":"Intravascular large B cell lymphoma presenting as cholecystitis:Diagnostic challenges persist","volume":"93","author":"Yadav","year":"2014","journal-title":"Ann Hematol"},{"key":"R34-20251208","doi-asserted-by":"crossref","first-page":"931","DOI":"10.5858\/2008-132-931-MPOCRF","article-title":"Metastatic patterns of cancers:Results from a large autopsy study","volume":"132","author":"Disibio","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"R35-20251208","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.5858\/2009-0580-RAR.1","article-title":"Neoplasia of gallbladder and biliary epithelium","volume":"134","author":"Katabi","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"R36-20251208","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4132\/KoreanJPathol.2012.46.5.429","article-title":"Expression of MUC1 and MUC4 in gallbladder adenocarcinoma","volume":"46","author":"Kim","year":"2012","journal-title":"Korean J Pathol"},{"key":"R37-20251208","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jso.22055","article-title":"Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder","volume":"105","author":"Xiong","year":"2012","journal-title":"J Surg Oncol"},{"key":"R38-20251208","first-page":"536","article-title":"Expression of Muc1 and Muc2 in intrahepatic bile duct and gallbladder carcinomas","volume":"35","author":"Sasaki","year":"2004","journal-title":"Hum Pathol"},{"key":"R39-20251208","first-page":"485","article-title":"MUC1 and MUC2 expression in human gallbladder carcinoma:A clinicopathological study and relationship with prognosis","volume":"8","author":"Kashiwagi","year":"2001","journal-title":"Oncol Rep"},{"key":"R40-20251208","first-page":"624","article-title":"The relationship between loss expression of DPC4\/Smad4 gene and carcinogenesis of pancreatobiliary carcinoma","volume":"1","author":"Tang","year":"2002","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R41-20251208","doi-asserted-by":"crossref","first-page":"173","DOI":"10.18231\/2394-6792.2018.0033","article-title":"Immunohistochemical expression of Ki-67 in gall bladder carcinoma","volume":"5","author":"Ojha","year":"2020","journal-title":"Indian J Pathol Oncol"},{"key":"R42-20251208","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.7314\/APJCP.2013.14.5.2711","article-title":"Cyclin D1, retinoblastoma and p16 protein expression in carcinoma of the gallbladder","volume":"14","author":"Srivastava","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"R43-20251208","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1309\/AJCPUJPGQIZ6DC6A","article-title":"Criteria for pathologic sampling of gallbladder specimens","volume":"140","author":"Adsay","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"R44-20251208","first-page":"86","article-title":"Routine histopathological examination of gallbladder specimens after cholecystectomy:Is it time to change the current practice?Turk J Surg","volume":"35","author":"Benkhadoura","year":"2018"},{"key":"R45-20251208","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00428-013-1478-1","article-title":"Early gallbladder carcinoma has a favorable outcome but Rokitansky-Aschoff sinus involvement is an adverse prognostic factor","volume":"463","author":"Roa","year":"2013","journal-title":"Virchows Arch"},{"key":"R46-20251208","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1440-1827.2008.02316.x","article-title":"Gallbladder adenocarcinoma arising in Rokitansky-Aschoff sinus","volume":"58","author":"Terada","year":"2008","journal-title":"Pathol Int"},{"key":"R47-20251208","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s13193-023-01778-w","article-title":"Xanthogranulomatous cholecystitis mimicking gall bladder cancer:A Diagnostic dilemma and review of literature","volume":"14","author":"Chauhan","year":"2023","journal-title":"Indian J Surg Oncol"},{"key":"R48-20251208","doi-asserted-by":"crossref","first-page":"e7411","DOI":"10.1590\/1414-431x20187411","article-title":"Pathogenesis of gallbladder adenomyomatosis and its relationship with early-stage gallbladder carcinoma:An overview","volume":"51","author":"Pang","year":"2018","journal-title":"Braz J Med Biol Res"},{"key":"R49-20251208","doi-asserted-by":"crossref","first-page":"206","DOI":"10.5858\/arpa.2022-0379-OA","article-title":"Adenomyomas of the gallbladder:An analysis of frequency, clinicopathologic associations, and relationship to carcinoma of a malformative lesion","volume":"148","author":"Dursun","year":"2024","journal-title":"Arch Pathol Lab Med"},{"key":"R50-20251208","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","article-title":"Gallbladder cancer","volume":"8","author":"Roa","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"R51-20251208","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/ijc.31916","article-title":"ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer","volume":"144","author":"Iyer","year":"2019","journal-title":"Int J Cancer"},{"key":"R52-20251208","doi-asserted-by":"crossref","first-page":"552","DOI":"10.5858\/arpa.2012-0032-OA","article-title":"Immunohistochemical expression of phospho-mTOR is associated with poor prognosis in patients with gallbladder adenocarcinoma","volume":"137","author":"Leal","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"R53-20251208","doi-asserted-by":"crossref","first-page":"894","DOI":"10.18632\/oncotarget.1808","article-title":"Role of aberrant PI3K pathway activation in gallbladder tumorigenesis","volume":"5","author":"Lunardi","year":"2014","journal-title":"Oncotarget"},{"key":"R54-20251208","first-page":"321","article-title":"Frequent beta-catenin alteration in gallbladder carcinomas","volume":"22","author":"Kimura","year":"2003","journal-title":"J Exp Clin Cancer Res"},{"key":"R55-20251208","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4137\/JCM.S40549","article-title":"KRAS mutation as a potential prognostic biomarker of biliary tract cancers","volume":"7","author":"Yokoyama","year":"2016","journal-title":"Jpn Clin Med"},{"key":"R56-20251208","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/modpathol.3800204","article-title":"The V599E BRAF mutation is uncommon in biliary tract cancers","volume":"17","author":"Goldenberg","year":"2004","journal-title":"Mod Pathol"},{"key":"R57-20251208","doi-asserted-by":"crossref","first-page":"22087","DOI":"10.1038\/s41598-020-77939-6","article-title":"Genomic profiling reveals high frequency of DNA repair genetic aberrations in gallbladder cancer","volume":"10","author":"Abdel-Wahab","year":"2020","journal-title":"Sci Rep"},{"key":"R58-20251208","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.gene.2015.10.004","article-title":"Epigenetic profiling of gallbladder cancer and gallstone diseases:Evaluation of role of tumour-associated genes","volume":"576","author":"Tekcham","year":"2016","journal-title":"Gene"},{"key":"R59-20251208","doi-asserted-by":"crossref","first-page":"100301","DOI":"10.1016\/j.labinv.2023.100301","article-title":"Diagnostic utility of next-generation sequencing in circulating free DNA and a comparison with matched tissue in gallbladder carcinoma","volume":"104","author":"Mishra","year":"2024","journal-title":"Lab Invest"},{"key":"R60-20251208","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12253-016-0087-0","article-title":"Quantification of circulating free DNA as a diagnostic marker in gall bladder cancer","volume":"23","author":"Kumari","year":"2017","journal-title":"Pathol Oncol Res"},{"key":"R61-20251208","doi-asserted-by":"crossref","first-page":"100928","DOI":"10.1016\/j.tranon.2020.100928","article-title":"Diagnostic value of quantification of circulating free DNA for gall bladder cancer using a chemiluminescence DNA biosensor system based on DNA G-quadruplex\/hemin enzyme","volume":"14","author":"Ying","year":"2021","journal-title":"Transl Oncol"},{"key":"R62-20251208","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/jgh3.12977","article-title":"Diagnostic value of quantification of cell-free DNA for suspected gallbladder cancer","volume":"7","author":"Sakamoto","year":"2023","journal-title":"JGH Open"},{"key":"R63-20251208","first-page":"3429","article-title":"EpCAM-based flow cytometric detection of circulating tumor cells in gallbladder carcinoma cases","volume":"18","author":"Awasthi","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"R64-20251208","first-page":"154320","article-title":"Circulating microRNAs in gallbladder cancer:Is serum assay of diagnostic value?Pathol Res Pract","volume":"242","author":"Srivastava","year":"2023"},{"key":"R65-20251208","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/cdd.2016.146","article-title":"MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway","volume":"24","author":"Shu","year":"2017","journal-title":"Cell Death Differ"},{"key":"R66-20251208","doi-asserted-by":"crossref","first-page":"7848","DOI":"10.3892\/mmr.2017.7520","article-title":"Decreased expression of hsa-miR-372 predicts poor prognosis in patients with gallbladder cancer by affecting chloride intracellular channel 1","volume":"16","author":"Zhou","year":"2017","journal-title":"Mol Med Rep"},{"key":"R67-20251208","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1038\/s41598-019-40857-3","article-title":"Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p","volume":"9","author":"Goeppert","year":"2019","journal-title":"Sci Rep"},{"key":"R68-20251208","doi-asserted-by":"crossref","first-page":"13914","DOI":"10.18632\/oncotarget.4227","article-title":"MicroRNA expression and its implications for diagnosis and therapy of gallbladder cancer","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"R69-20251208","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ncrna.2024.02.005","article-title":"Panel of serum long non-coding RNAs as potential non-invasive biomarkers for gallbladder carcinoma","volume":"9","author":"Mishra","year":"2024","journal-title":"Noncoding RNA Res"},{"key":"R70-20251208","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s42047-025-00188-2","article-title":"Biogenesis, function and role of circular RNA in gallbladder carcinoma:A narrative review","volume":"8","author":"Singh","year":"2025","journal-title":"Surg Exp Pathol"},{"key":"R71-20251208","first-page":"97","article-title":"Detection of circulating tumor cells in cancers of biliary origin","volume":"3","author":"Al","year":"2012","journal-title":"J Gastrointest Oncol"},{"key":"R72-20251208","first-page":"13590","article-title":"The longitudinal change of circulating tumor cell during chemotherapy and its correlation with disease features, treatment response and survival profile of advanced gallbladder carcinoma","volume":"13","author":"Wang","year":"2021","journal-title":"Am J Transl Res"},{"key":"R73-20251208","doi-asserted-by":"crossref","first-page":"7966","DOI":"10.1245\/s10434-023-14231-7","article-title":"Circulating tumor cells are an independent risk factor for poor prognosis in patients with gallbladder adenocarcinoma","volume":"30","author":"Yan","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"R74-20251208","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1186\/s12885-025-14140-w","article-title":"Enumeration, classification and clinical application of circulating tumor cells in advanced gallbladder adenocarcinoma","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Cancer"},{"key":"R75-20251208","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12253-017-0380-6","article-title":"Diagnostic value of circulating free DNA integrity and global methylation status in gall bladder carcinoma","volume":"25","author":"Kumari","year":"2019","journal-title":"Pathol Oncol Res"},{"key":"R76-20251208","first-page":"127","article-title":"Surgical procedures for gallbladder cancer","volume":"127","author":"Kapoor","year":"2014","journal-title":"Surg Update"},{"key":"R77-20251208","doi-asserted-by":"crossref","first-page":"44","DOI":"10.21037\/cco.2019.08.14","article-title":"Systemic therapy for gallbladder cancer","volume":"8","author":"Javle","year":"2019","journal-title":"Chin Clin Oncol"},{"key":"R78-20251208","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S1470-2045(21)00336-3","article-title":"Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway):A multicentre, open-label, phase 2a, multiple basket study","volume":"22","author":"Javle","year":"2021","journal-title":"Lancet Oncol"},{"key":"R79-20251208","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1200\/JCO.2005.05.3579","article-title":"Phase II study of erlotinib in patients with advanced biliary cancer","volume":"24","author":"Philip","year":"2006","journal-title":"J Clin Oncol"},{"key":"R80-20251208","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1470-2045(09)70333-X","article-title":"Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome:A phase 2 study","volume":"11","author":"Zhu","year":"2010","journal-title":"Lancet Oncol"},{"key":"R81-20251208","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/cas.13438","article-title":"Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine","volume":"109","author":"Ikeda","year":"2018","journal-title":"Cancer Sci"},{"key":"R82-20251208","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s10637-014-0096-3","article-title":"Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumors","volume":"32","author":"Costello","year":"2014","journal-title":"Invest New Drugs"},{"key":"R83-20251208","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/his.13669","article-title":"Clinical relevance of PD-L1 expression in gallbladder cancer:A potential target for therapy","volume":"73","author":"Neyaz","year":"2018","journal-title":"Histopathology"},{"key":"R84-20251208","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3390\/cancers13071682","article-title":"Programmed death ligand-1 (PD-L1) is an independent negative prognosticator in western-world gallbladder cancer","volume":"13","author":"Albrecht","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R85-20251208","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1186\/s12967-023-04589-3","article-title":"Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer","volume":"21","author":"He","year":"2023","journal-title":"J Transl Med"}],"container-title":["Indian Journal of Pathology and Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpm.ijpm_649_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:50:29Z","timestamp":1787068229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpm.ijpm_649_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":84,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ijpm.ijpm_649_25","relation":{},"ISSN":["0377-4929","0974-5130"],"issn-type":[{"value":"0377-4929","type":"print"},{"value":"0974-5130","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"2025-06-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}